Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

The family of Henrietta Lacks settles lawsuit with Novartis over use of her cells, marking a turning point in fight for ...

The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.

NorthX Biologics and Demeetra today announced a strategic collaboration combining a best-in-class high-titer GS (-/-) CHO cell line with full freedom to operate and no additional IP-related costs, ...

The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...

Amatera’s approach is “2x faster and 10x more cost-effective” than industry standards for developing new varieties of perennials, it claims.

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

California-based solar EV developer Aptera Motors has built the first vehicle on its validation assembly line. The company ...

Despite innovative new research, many cell and gene therapies do not make it all the way to the patients. Researchers and clinicians in Lund have now presented a new model for cooperation that will ...

Uttar Pradesh sets up ‘Kaushal Connect Cell’ to link skilled youth with major industries, strengthening its push toward a $1 ...

Konstanz, a leading global institute for applied photovoltaic (PV) research, today announced a strategic partnership with Celloraa Energy through MoU, to support the ramp-up of 1.2 GW of ...